Clinical Trials · NCT07747805
GLP-1 Agonists for Lung Function Improvement and Muscle Restoration in COPD
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- The Cleveland Clinic
- Enrollment
- 30
- Start date
- Aug 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in FEV1